Harris Teeter ultra strength antacid tablets contain metallic particles
Harris Teeter Ultra Strength Antacid, calcium carbonate 1000 mg, is being recalled because of the presence of small metallic particles in the chewable tablets.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 3/5 (High).
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: Metallic particles in a chewable tablet are a physical hazard capable of causing injury, a risk of harm with no injuries reported in the source.
Plain-English summary
Harris Teeter Ultra Strength Antacid, calcium carbonate 1000 mg, 72 chewable tablets, distributed by Harris Teeter, LLC of Matthews, North Carolina, UPC 0 72036-73108-1, is being recalled.
The stated reason is the presence of a foreign substance: small metallic particles in the chewable tablets. The FDA classified the action as Class II.
The affected lot is 1716089, expiring January 2029. Distribution was USA nationwide.
Consumers who have the affected lot should stop using it and return it to the place of purchase. Anyone injured after taking the tablets should seek medical advice.
The recalled product
- Product
- Harris Teeter, ULTRA STRENGTH ANTACID, Calcium Carbonate 1000 mg, 72 CHEWABLE TABLETS, Distributed by: Harris Teeter, LLC.,MATTHEWS, NC 28105, UPC: 0 72036-73108-1.
- Manufacturer
- Guardian Drug Co. Inc.
- Category
- Drug — Antacid tablet
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 1716089
- expires: JAN 2029.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 23 recalled by Guardian Drug Co. Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 23 products in this recall →Related recalls
Same manufacturer · Guardian Drug Co. Inc.
See all →- HighCareOne extra strength calcium antacid tablets contain metallic particles
FDA (Drugs) · 2026-06-10
- HighGoodSense ultra strength antacid tablets contain small metallic particles
FDA (Drugs) · 2026-06-10
- HighCareOne ultra strength antacid tablets contain small metallic particles
FDA (Drugs) · 2026-06-10
- HighEqualine extra strength antacid tablets contain small metallic particles
FDA (Drugs) · 2026-06-10
- HighGoodSense antacid chewable tablets contain small metallic particles
FDA (Drugs) · 2026-06-10
Same hazard · foreign object
See all →- ModerateTeva Recalls Metoclopramide Tablets Due to Foreign Object Presence
FDA (Drugs) · 2026-10-21
- ModerateMetoclopramide Tablets Recalled Due to Presence of Foreign Tablets or Capsules
FDA (Drugs) · 2026-10-21
- ModerateStewart's Shops Vanilla Heavenly Medley Recalled for Metal Pieces
FDA (Food) · 2026-10-21
- ModerateMezzetta Golden Greek Peperoncini Recalled for Potential Mouse Contamination
FDA (Food) · 2026-10-14
- SevereUnited and Good & Gather Light Brown Sugar Recalled for Wheat Contamination
FDA (Food) · 2026-09-30
Similar recalls
- HighL. Perrigo Recalls Calcium Carbonate Antacid Tablets Due to Metal Particles
FDA (Drugs) · 2018-11-28
- HighTUMS Antacid 1000 mg Chewable Tablets Recalled for Glass Mineral Wool Contamination
FDA (Drugs) · 2023-11-08
- HighTUMS Antacid Tablets Recalled for Glass Mineral Wool Contamination
FDA (Drugs) · 2023-11-08
- LowNovartis Recalls Maalox Extra Strength Antacid Tablets Due to Illegible Labeling
FDA (Drugs) · 2013-08-28
- LowNovartis Recalls Maalox Antacid Tablets Due to Illegible Labeling
FDA (Drugs) · 2013-08-28
- ModerateNutralox Mint Antacid Chewable Tablets Recalled for cGMP Deviations
FDA (Drugs) · 2022-02-09